JPWO2023021184A5 - - Google Patents
Info
- Publication number
- JPWO2023021184A5 JPWO2023021184A5 JP2024509397A JP2024509397A JPWO2023021184A5 JP WO2023021184 A5 JPWO2023021184 A5 JP WO2023021184A5 JP 2024509397 A JP2024509397 A JP 2024509397A JP 2024509397 A JP2024509397 A JP 2024509397A JP WO2023021184 A5 JPWO2023021184 A5 JP WO2023021184A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antisense oligonucleotide
- adk
- compound
- therapeutic rna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA202170418 | 2021-08-19 | ||
| DKPA202170418 | 2021-08-19 | ||
| PCT/EP2022/073188 WO2023021184A1 (en) | 2021-08-19 | 2022-08-19 | Antisense oligonucleotides targeting adenosine kinase |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024531342A JP2024531342A (ja) | 2024-08-29 |
| JPWO2023021184A5 true JPWO2023021184A5 (https=) | 2025-08-05 |
| JP2024531342A5 JP2024531342A5 (https=) | 2025-08-05 |
Family
ID=83280116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509397A Pending JP2024531342A (ja) | 2021-08-19 | 2022-08-19 | アデノシンキナーゼを標的とするアンチセンスオリゴヌクレオチド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250136990A1 (https=) |
| EP (1) | EP4388096A1 (https=) |
| JP (1) | JP2024531342A (https=) |
| CN (1) | CN118265785A (https=) |
| AU (1) | AU2022329462A1 (https=) |
| CA (1) | CA3228833A1 (https=) |
| WO (1) | WO2023021184A1 (https=) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU9063398A (en) | 1997-09-12 | 1999-04-05 | Exiqon A/S | Oligonucleotide analogues |
| CN1350542A (zh) | 1999-03-18 | 2002-05-22 | 埃克西库恩公司 | 木－lna类似物 |
| JP4768132B2 (ja) | 1999-03-24 | 2011-09-07 | エクシコン エ／エス | ［２．２．１］ビシクロヌクレオシドの改良された製法 |
| IL148916A0 (en) | 1999-10-04 | 2002-09-12 | Exiqon As | Design of high affinity rnase h recruiting oligonucleotide |
| JP4413493B2 (ja) | 2000-10-04 | 2010-02-10 | サンタリス ファーマ アー／エス | プリンｌｎａ類似体の改善された合成方法 |
| AU2002328792A1 (en) | 2001-07-12 | 2003-01-29 | Santaris Pharma A/S | Method for preparation of lna phosphoramidites |
| JP4476802B2 (ja) | 2002-05-08 | 2010-06-09 | サンタリス ファーマ アー／エス | ロックト核酸誘導体の製造 |
| US7481672B2 (en) | 2005-07-21 | 2009-01-27 | Rosemount Tank Radar Ab | Dielectric connector, DC-insulating through-connection and electronic system |
| WO2007031091A2 (en) | 2005-09-15 | 2007-03-22 | Santaris Pharma A/S | Rna antagonist compounds for the modulation of p21 ras expression |
| US20070203086A1 (en) * | 2006-02-24 | 2007-08-30 | Detlev Boison | Adenosine therapy via interfering RNA |
| CA2648132C (en) | 2006-04-03 | 2019-05-28 | Santaris Pharma A/S | Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| CN104136451A (zh) | 2011-09-07 | 2014-11-05 | 玛瑞纳生物技术有限公司 | 具有构象限制的单体的核酸化合物的合成和用途 |
| KR20160083876A (ko) | 2013-11-14 | 2016-07-12 | 로슈 이노베이션 센터 코펜하겐 에이/에스 | ApoB 안티센스 접합체 화합물 |
| JP2024522272A (ja) * | 2021-06-04 | 2024-06-13 | ニューミルナ セラピューティクス エーピーエス | アデノシンキナーゼを標的とするアンチセンスオリゴヌクレオチド |
-
2022
- 2022-08-19 CA CA3228833A patent/CA3228833A1/en active Pending
- 2022-08-19 EP EP22768654.0A patent/EP4388096A1/en active Pending
- 2022-08-19 AU AU2022329462A patent/AU2022329462A1/en active Pending
- 2022-08-19 US US18/683,659 patent/US20250136990A1/en active Pending
- 2022-08-19 CN CN202280062861.5A patent/CN118265785A/zh active Pending
- 2022-08-19 WO PCT/EP2022/073188 patent/WO2023021184A1/en not_active Ceased
- 2022-08-19 JP JP2024509397A patent/JP2024531342A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5545729A (en) | Stabilized ribozyme analogs | |
| Crooke | Molecular mechanisms of action of antisense drugs | |
| Morris | siRNA-mediated transcriptional gene silencing: the potential mechanism and a possible role in the histone code | |
| EP3556859B1 (en) | Selective antisense compounds and uses thereof | |
| JP2021510511A5 (https=) | ||
| FI4220360T3 (fi) | Oligonukleotideja paternaalisen ube3a:n ilmentämiseksi | |
| RU2017127609A (ru) | Антисмысловые олигомеры тау-белка и их применение | |
| AU3751299A (en) | Nucleic acid molecules with novel chemical compositions capable of modulating gene expression | |
| JPWO2019165067A5 (https=) | ||
| JP2011256171A (ja) | 増強されたアンチセンスオリゴヌクレオチド | |
| AU2004274942A1 (en) | Modulation of eIF4E expression | |
| CA2457528A1 (en) | Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina) | |
| WO2005002507A2 (en) | Modulation of survivin expression | |
| IL275903B1 (en) | Antisense oligonucleotides targeting alpha-synuclein and uses thereof | |
| FI3717646T3 (fi) | Angelmanin oireyhtymän antisense-hoito | |
| JP2004507272A (ja) | アラビノフラノース類似体およびデオキシリボースヌクレオチドのキメラアンチセンス | |
| Abe et al. | Specific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by circular dumbbell RNA/DNA chimeric oligonucleotides containing antisense phosphodiester oligonucleotides | |
| JPWO2019140236A5 (https=) | ||
| AU4155396A (en) | Ribozyme analogs | |
| Nurmi et al. | A modified X10-23 DNAzyme that can better access large, structured RNA targets | |
| JPWO2023021184A5 (https=) | ||
| WO2008103060A1 (en) | A sirna sequence, vector, a molecular target for sirna reagents and vectors introduced into cells and tissues, a method of evaluating the specificity of the silencing of the mutated transcript, a method of examining the interactions of enzymes on the rnai pathway with transcripts as well as the application of the sirna sequ | |
| CA3221935A1 (en) | Asymmetric short duplex dna as a novel gene silencing technology and use thereof | |
| CA3221923A1 (en) | Short duplex dna as a novel gene silencing technology and use thereof | |
| JPWO2021232099A5 (https=) |